FDA Approves OXYCODONE AND ACETAMINOPHEN — Amneal Pharmaceuticals of New York LLC
Amneal Pharmaceuticals of New York LLC announced the FDA approval of its generic oxycodone and acetaminophen tablet, a milestone expected to bolster the company's presence in the competitive opioid analgesic market by increasing access to affordable pain management options.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day